San Diego—Genetic testing holds the promise to improve pain management and prevent opioid abuse and addiction, according to a new study.
The study, presented at the 2017 American Association for Clinical Chemistry Annual Scientific Meeting & Clinical Lab Expo, identified genetic factors largely not evaluated in clinical practice that play a role in prescription opioid addiction. Lead author Sherman Chang, MD, and his colleagues used oral specimens from 70 patients addicted to opioids